ACM
ABBV icon

Advance Capital Management’s AbbVie ABBV Stock Holding History

Advance Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$667K Buy
3,066
+36
+1% +$7.99K 0.03% 92
2025
Q4 		$692K Buy
3,030
+23
+0.8% +$5.24K 0.03% 89
2025
Q3 		$696K Sell
3,007
-312
-9% -$63.5K 0.03% 89
2025
Q2 		$616K Buy
3,319
+5
+0.2% +$929 0.03% 94
2025
Q1 		$694K Sell
3,314
-4
-0.1% -$778 0.03% 80
2024
Q4 		$590K Buy
3,318
+66
+2% +$12.1K 0.03% 81
2024
Q3 		$642K Buy
3,252
+513
+19% +$95.7K 0.03% 79
2024
Q2 		$470K Sell
2,739
-163
-6% -$27K 0.02% 91
2024
Q1 		$528K Buy
2,902
+48
+2% +$8.27K 0.04% 82
2023
Q4 		$442K Sell
2,854
-141
-5% -$20.6K 0.03% 74
2023
Q3 		$446K Buy
2,995
+403
+16% +$59.2K 0.04% 72
2023
Q2 		$349K Buy
2,592
+815
+46% +$120K 0.04% 81
2023
Q1 		$283K Buy
1,777
+1
+0.1% +$153 0.05% 84
2022
Q4 		$287K Sell
1,776
-140
-7% -$21.5K 0.04% 82
2022
Q3 		$257K Buy
1,916
+228
+14% +$32.7K 0.03% 73
2022
Q2 		$259K Buy
1,688
+4
+0.2% +$611 0.03% 68
2022
Q1 		$273K Buy
1,684
+75
+5% +$10.9K 0.03% 69
2021
Q4 		$218K Buy
+1,609
New +$190K 0.04% 80

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advance Capital Management's ABBV Position: Q1 2026 in Review

Advance Capital Management increased its AbbVie (ABBV) stake by 1.2% in Q1 2026, buying an estimated $7.99K and bringing the position to 3,066 shares worth $667K. The position accounts for 0.03% of the portfolio, ranked #92.

Advance Capital Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $696K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Advance Capital Management held 3,066 shares of AbbVie worth $667K as of Q1 2026.
  • Advance Capital Management bought 36 AbbVie shares in Q1 2026, an estimated $7.99K.
  • AbbVie made up 0.03% of Advance Capital Management's portfolio in Q1 2026, its #92 holding.
  • Advance Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Advance Capital Management's AbbVie position peaked at $696K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Advance Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.